Stem cells, engineering and FACS

Biofabrication and Tissue Engineering Facility

The Biofabrication and Tissue Engineering Facility (Biofab) offers a diverse range of micro and nanostructuring techniques for a wide scope of applications in the fields of life-science and medicine. The Biofab aims to bridge the gap between engineering and biology at Karolinska Institutet and to provide common grounds with respect to suitable material of use of modular design and tunable structures for biomedical purposes.

Biomedicum Flow Cytometry Core Facility

Biomedicum Flow Cytometry (BFC) Core Facility is a shared resource laboratory that will provide researchers with the capability of performing a wide range of flow cytometry experiments.

CRISPR Functional Genomics

The CRISPR Functional Genomics facility (CFG) offers a wide array of CRISPR applications, ranging from precision genome engineering in cell lines to massively parallel genetic perturbations for genetic screening and unbiased discovery. As a SciLifeLab national infrastructure unit, CFG strives to provide services at the cutting edge of technological innovation. Please note that the Karolinska Genome Engineering Facility (KGE) is now a part of CFG.

Developmental Tissue Bank

The Developmental Tissue Bank provides research groups with defined human embryonic and fetal tissue (“prenatal tissue”), derived from routine abortions, through a collaboration with various clinics. After the tissue is transferred to the facility, we determine the developmental stage, identify the retrieved tissue, perform any necessary dissection, and process the tissue as agreed with the user.

Flemingsberg Flow Cytometry Facility

The Flemingsberg Flow Cytometry Core Facility (FCC) at Karolinska Institutet (KI) provides flow cytometry analysis and cell sorting, both assisted and non-assisted, for KI and Karolinska University Hospital researchers, as well as users from other universities and companies.

Karolinska Institutet Stem Cell Organoid

The main goal of Karolinska Institutet Stem Cell Organoid (KISCO) is to assist researchers, mainly within the university and in Sweden, to harbour the potential of pluripotent stem cells (PSCs) in studying complex human disease mechanisms. A key tool offered and that will be continuously developed is the derivation and use of in vitro organoid systems of mouse and human stem cell origin. KISCO is unique in offering these services as a core facility in Sweden.